Objective: Accumulating evidence has implicated insulin and the insulin-like growth factor (IGF) axis in colorectal carcinogenesis. Of interest, adiposity is likely to impose a greater risk on men than on women, which indicates that the association of insulin and the IGF axis with colorectal neoplasia may differ by gender. However, epidemiological evidence for this possible gender difference is limited to date. Methods: We measured plasma concentrations of C-peptide, IGF-I and IGF-binding proteins (IGFBPs) 1 and 3 in 1520 healthy volunteer examinees who underwent total colonoscopy between February 2004 and February 2005, and cross-sectionally investigated the association of these biomarkers with colorectal adenoma by gender. An unconditional logistic regression model was used to estimate odds ratios (ORs) and their 95% confidence intervals (CIs) for colorectal adenoma after adjustment for potential confounders. Results: We observed a positive association of C-peptide and IGF-I (P trend o0.001 and 0.02, respectively) and an inverse association of IGFBP-1 (P trend ¼ 0.002) with colorectal adenoma in men. Adjusted ORs of colorectal adenoma for the highest compared with the lowest quartile were also statistically significant for C-peptide (OR: 2.62, 95% CI: 1.71-4.01), IGF-I (OR: 1.63, 95% CI: 1.08-2.46) and IGFBP-1 (OR: 0.49, 95% CI: 0.32-0.75). In contrast, no measurable association was seen in women. Corresponding ORs for C-peptide, IGF-I and IGFBP-1 were 0.98 (95% CI: 0.56-1.71), 0.79 (95% CI: 0.44-1.43) and 1.05 (95% CI: 0.60-1.86), respectively. The gender difference was statistically significant for C-peptide (P interaction ¼ 0.03) and marginally significant for IGF-I and IGFBP-1 (P interaction ¼ 0.14 and 0.12, respectively). Conclusion: Our observations suggest that insulin and the IGF axis act differently by gender in colorectal carcinogenesis, at least in its early stage. The findings of this study further our understanding of the complexities of the gender difference in the association between adiposity and colorectal neoplasia.
Introduction
Colorectal cancer is a global health concern, with more than 1 200 000 new cases and 600 000 deaths worldwide in 2008. 1 Major high-risk areas are North American and European countries, 1 where the prevalence of overweight and obesity is remarkably high. 2 In particular, epidemiological studies have consistently revealed the association of overweight and obesity with an increased risk of colorectal cancer and adenoma, a well-established precursor lesion of colorectal cancer. 3, 4 Although the biological mechanisms of the potential association between adiposity and colorectal neoplasia have not been fully elucidated, accumulating evidence has implicated insulin and the insulin-like growth factor (IGF) axis in colorectal carcinogenesis. [4] [5] [6] [7] Adiposity is a major determinant of insulin resistance and subsequent hyperinsulinemia, 8 while insulin has the potential to directly stimulate the growth of colonic epithelial and carcinoma cells in vitro, albeit its tumorigenic effects appear to operate mainly through the IGF axis in vivo. [4] [5] [6] [7] The IGF axis is a complex molecular network in which IGF-I interacts with several IGF-binding proteins (IGFBPs) to regulate cell proliferation and apoptosis. [4] [5] [6] [7] Although IGFBP-3 is the predominant binding protein of IGF-I in the circulation, its concentrations are relatively stable regardless of the degree of adiposity. 5 In contrast, circulating levels of IGFBP-1 are closely related to adiposity, 5 and influence IGF-I bioavailability. [4] [5] [6] [7] Further, IGFBP-1 provides a connection between insulin and the IGF axis, wherein prolonged hyperinsulinemia reduces the production of IGFBP-1 from the liver. [4] [5] [6] [7] Of interest, adiposity is likely to impose a greater risk on men than on women, 3, 4 which indicates that insulin and the IGF axis may act differently by gender in colorectal tumorigenesis. However, epidemiological evidence for this possible gender difference is limited to date, and few previous studies have examined the association of insulin and the IGF axis with colorectal neoplasia for men and women separately in the same study settings. 9, 10 Here, we measured plasma concentrations of C-peptide, a biomarker of pancreatic insulin secretion, IGF-I, IGFBP-1 and IGFBP-3 among middle-aged and elderly Japanese, and compared the association of these biomarkers with colorectal adenoma between men and women.
Subjects and methods

Study design and population
The Research Center for Cancer Prevention and Screening, a branch of the National Cancer Center of Japan, conducted the Colorectal Adenoma Study in Tokyo, [11] [12] [13] a case-control study specifically designed to investigate environmental and genetic factors related to the early stage of colorectal carcinogenesis among healthy volunteer examinees of a colorectal cancer screening. All examinees gave written informed consent to allow their data and materials collected through the screening to be used for medical research. The study protocol was approved by the institutional review board of the National Cancer Center. Eligible subjects were defined in advance as men aged 50-79 years and women aged 40-79 years who underwent total colonoscopy from the anus to the cecum and were without a history of colorectal adenoma, any malignant neoplasia, ulcerative colitis, Crohn's disease, familial adenomatous polyposis, carcinoid tumor or colectomy. Of a consecutive series of 3212 examinees undergoing magnifying colonoscopy with indigo carmine dye spraying between February 2004 and February 2005, 2234 met these conditions. On the basis of the pit pattern of colorectal lesions, namely, the characteristics of mucosal crypts, 526 men and 256 women were determined to have at least one adenoma and were thus included as adenoma cases. Pit-pattern classification based on magnifying chromoendoscopy has been detailed elsewhere.
14 Of the remaining 1452 examinees, we identified 482 men and 721 women as potential controls who were also free from other benign lesions (for example, hyperplastic polyps, inflammatory polyps and diverticula). As there were fewer potential controls than cases in men, all potential male controls were included in the study, whereas female controls were randomly selected from potential controls, and frequency matched to the female cases in five age categories (40-49, 50-54, 55-59, 60-64 and X65 years of age) and two screening periods (first and second halves). Finally, the study enrolled 526 cases and 482 controls in men, and 256 cases and 256 controls in women. Cases with adenomas of X5 mm in diameter were referred to clinical hospitals for definitive diagnosis and treatment.
Blood collection and laboratory procedures Examinees were scheduled for blood collection before any cancer screening procedures on the first day of screening.
Fasting venous blood was drawn into a vacutainer tube with ethylenediaminetetraacetic acid. All but three examinees had fasted for 4 h or more. The vacutainer tubes were centrifuged to obtain blood plasma and buffy coat, and the specimens were preserved at À80 1C until analysis. Plasma C-peptide concentrations were measured by a chemiluminescent enzyme immunoassay method using a commercially available reagent (Fujirebio, Tokyo, Japan) at SRL, Tokyo, Japan. The laboratory reported the minimum detection level of plasma C-peptide as 0.04 ng ml À1 and the intra-and inter-assay coefficients of variation of plasma C-peptide as 2.29% (n ¼ 10, mean concentration: 0.738 ng ml
À1
) and 3.81% (n ¼ 4, mean concentration: 2.98 ng ml À1 ), respectively. Plasma concentrations of IGF-I, IGFBP-1 and IGFBP-3 were analyzed by immunoradiometric assay methods using commercially available reagents (IGF-I: Mitsubishi Chemical Medience, Tokyo, Japan; IGFBP-1 and IGFBP-3: Diagnostic Systems Laboratories, Webster, TX, USA) at Mitsubishi Chemical Medience. Of note, the analysis of IGF-I measured total, and not free, IGF-I levels, and the analyses of IGFBP-1 and IGFBP-3 were performed using the same method and reagents as most previous studies had adopted. In addition, the measurements of IGF-I, IGFBP-1 and IGFBP-3 were conducted using the same reagents at the same external laboratory as in our previous study of colorectal cancer, 9 and their coefficients of variation were not specifically reported for the present study. All laboratory personnel were blinded with respect to case and control status. The limited specimen volume did not allow us to measure all four biomarkers in a duplicate manner.
Self-administered questionnaire
Before cancer screening, all examinees were encouraged to complete a self-administered questionnaire concerning lifestyle and socioeconomic characteristics, as well as personal and family medical history. Details of the questionnaire have been described elsewhere. [11] [12] [13] In brief, the questionnaire inquired about smoking habits by first determining smoking status (current, past and never) and then expressing lifetime exposure to cigarette smoking among ever smokers (that is, past and current smokers) by pack-years, with one pack-year defined as the smoking of 20 cigarettes every day for one year. The questionnaire also enquired about drinking habits by first determining drinking Insulin-related factors and colorectal neoplasia T Yamaji et al status (current, past and never) and then calculating the amount of alcohol consumed per week among current drinkers on the basis of the frequency of alcohol drinking and the number of standard units consumed per occasion for five different alcoholic beverages (sake, shochu/awamori, beer, whisky and wine).
In the questionnaire, examinees were asked about the average amount of time spent per day in four types of physical activity during working hours (sitting, standing, walking and physically working) and about the average frequency and average amount of time spent per occasion in four levels of physical activity during leisure time (very light, light, moderate and heavy). Occupational and leisure-time physical activities were calculated from the responses, respectively, and expressed by metabolic equivalent task hours per day. Total physical activity was the sum of occupational and leisure-time physical activities.
The questionnaire also included a food frequency questionnaire of 145 food and beverage items, with standard portions/units and 9 frequency categories. The amount of each food consumed per day in the past year was first calculated from the responses, and then total energy and nutrient intakes were estimated by reference to the Standard Tables of Food Composition in Japan, Fifth Revised Edition. 15 Visceral fat volume and anthropometric measurements Visceral fat volume was quantified using specifically designed software (Fujifilm Medical, Tokyo, Japan). 11 To measure visceral fat volume, we first selected a series of multi-slice computed tomography images from immediately below the diaphragmatic surface of the heart to the cranial edge of the pubic symphysis. Visceral fat area was then computed in each image by electronically determining pixels, with attenuation values between À190 and À30 Hounsfield units in the intra-abdominal region. Finally, visceral fat volume was calculated by integrating these visceral fat areas of respective images with a 5-mm slice thickness. Body weight and height were measured objectively at the beginning of cancer screening. Body mass index was calculated as the weight in kilograms divided by the squared height in meters.
Statistical analysis
An unconditional logistic regression model was used to estimate odds ratios (ORs) and their 95% confidence intervals (CIs) of colorectal adenoma according to genderspecific quartiles of C-peptide, IGF-I, IGFBP-1 and IGFBP-3, with the lowest quartile for each biomarker used as the reference. Statistical adjustment was similar to that in our previous study of visceral adiposity. 11 The first analysis controlled for matching variables (that is, age categories and screening periods) and the duration of fasting (o10 h or X10 h), whereas the second additionally adjusted for the following covariates: cigarette smoking (never, p20, 21-40 and 440 pack-years), alcohol drinking (never, past, o150, 150-299 and X300 g per week), family history of colorectal cancer (yes or no) and non-steroidal anti-inflammatory drug use (yes or no). The second analysis also adjusted for average daily energy intake in the past year and adult attained height, the latter of which is an indicator of gross energy intake in childhood and adolescence. These two variables were divided into quartiles, the cutoff points of which were based on the gender-specific distribution among controls. Major determinants of insulin resistance, namely, body mass index and physical activity, were included not in the second analysis but in the sensitivity analysis, because insulin and the IGF axis likely mediate the effect of insulin resistance on colorectal neoplasia. Linear trends in the ORs of colorectal adenoma were also assessed by assigning ordinal values to quartiles of respective biomarkers. Finally, we examined whether gender modified the association of C-peptide, IGF-I, IGFBP-1 and IGFBP-3 with colorectal adenoma. To evaluate these interactions by gender, we adopted the same statistical method as in our previous study of visceral adiposity.
11
Of 1517 study subjects who had fasted for 4 h or more, 206 had fasting glucose levels of 110 mg dl À1 or more. In addition to these, 3 with missing information for cigarette smoking were excluded, leaving 848 men (437 cases, 411 controls) and 460 women (229 cases, 231 controls) for inclusion. Twosided P-values o0.05 were regarded as statistically significant. All statistical analyses were carried out using SAS version 9.1 (SAS Institute, Cary, NC, USA).
Results
Selected characteristics of controls according to C-peptide level by gender Tables 1 and 2 summarize selected characteristics of controls according to C-peptide level in men and women, respectively. Increasing C-peptide levels were significantly related to lower IGFBP-1 concentrations and higher glucose concentrations, body mass index and visceral fat volume in both men and women. In addition, prevalence of ever smoking and plasma concentrations of IGF-I and IGFBP-3 differed substantially by C-peptide levels among men, but marginally among women.
Association of C-peptide, IGF-I, IGFBP-1 and IGFBP-3 with colorectal adenoma by gender Tables 3 and 4 show the ORs of colorectal adenoma according to gender-specific quartiles of C-peptide, IGF-I, IGFBP-1, and IGFBP-3 in men and women, respectively. In men, we observed a statistically significant trend of increasing adjusted ORs for colorectal adenoma across quartiles of C-peptide and IGF-I (P trend o0.001 and 0.02, respectively). In contrast, a decreasing trend was statistically significant for IGFBP-1 (P trend ¼ 0.002). Adjusted ORs of colorectal adenoma Insulin-related factors and colorectal neoplasia T Yamaji et al mass index and physical activity, which remained statistically significant for C-peptide and IGFBP-1 (Table 3 ). In the sensitivity analyses for C-peptide and IGFBP-1, the ORs of colorectal adenoma for a 5-kg m À2 increase in body mass index were 1.08 (95% CI: 0.79-1.48) and 1.17 (95% CI: 0.85-1.60), respectively, neither of which was statistically Insulin-related factors and colorectal neoplasia T Yamaji et al significant (P40.30). When C-peptide, IGF-I and IGFBP-1 were treated as continuous variables, adjusted ORs of colorectal adenoma for a 1 standard deviation increase were 1.37 (95% CI: 1.18-1.59), 1.15 (95% CI: 1.00-1.33; P ¼ 0.049) and 0.81 (95% CI: 0.70-0.94), respectively. This continuous analysis was conducted after natural logarithmic transformation of each biomarker. Of note, we did not observe any measurable association in women (Table 4) . Adjusted ORs for the highest compared with the lowest quartile of C-peptide, IGF-I and IGFBP-1 were 0.98 (95% CI: 0.56-1.71), 0.79 (95% CI: 0.44-1.43) and 1.05 (95% CI: 0.60-1.86), respectively. The gender difference was statistically significant for C-peptide (P interaction ¼ 0.03) and marginally significant for IGF-I and IGFBP-1 (P interaction ¼ 0.14 and 0.12, respectively). These results did not change essentially even after excluding postmenopausal women under hormone replacement therapy (n ¼ 49; data not shown).
Discussion
In this study, we measured plasma concentrations of C-peptide, IGF-I, IGFBP-1 and IGFBP-3 in healthy volunteer examinees of a colorectal cancer screening, and observed a positive association of C-peptide and IGF-I and an inverse association of IGFBP-1 with colorectal adenoma in men. In contrast, no measurable association was seen in women. The gender difference was particularly obvious for C-peptide, while suggestive for IGF-I and IGFBP-1. In addition, the observed association of C-peptide and IGFBP-1 in men remained significant even after adjustment for body mass index, whereas body mass index was not associated with colorectal adenoma after adjustment for each of these biomarkers. These findings may suggest that insulin and the IGF axis have an independent role in colorectal carcinogenesis beyond a simple role as an intermediate between adiposity and colorectal neoplasia, at least in men. The association of insulin and the IGF axis with colorectal adenoma has been investigated in at least 10 studies to date. 10, [16] [17] [18] [19] [20] [21] [22] [23] [24] Nevertheless, all were conducted in only three countries, the United States, the United Kingdom and Japan, and significant associations were mainly reported in the former two countries. This discrepancy is probably best explained as the sum of several differences in demographic characteristics between Japan and the other two countries including genetic predisposition. Nevertheless, a notable explanatory factor is body size, which exerts a strong influence on insulin and the IGF axis and which substantially differs between Japan and the other two countries, with a prevalence of overweight and obesity of less than one in four adults in Japan versus more than one in two in both the United States and the United Kingdom. 2 Our observations of a gender difference for C-peptide agree with those from a case-control study of colorectal cancer nested in a large prospective cohort study among a Japanese population, in which a statistically significant association was seen between plasma C-peptide concentrations and the risk of colorectal cancer only in men. 9 Further, a recent metaanalysis of prospective studies reported that men with higher C-peptide/insulin levels had a much greater risk of colorectal cancer than women with similar levels. 25 In contrast, epidemiological evidence for the gender difference in the association of IGFs and IGFBPs with colorectal neoplasia is sparse. In fact, there are only two studies of colorectal neoplasia in which circulating levels of these biomarkers were investigated for men and women separately in the same study settings, albeit both studies did not find any association in either men or women. 9, 10 Further, no meta-analysis has been conducted for men and women separately to date. Although previous studies have not focused on the potential importance of gender differences in the association of insulin and the IGF axis with colorectal neoplasia, a mounting body of evidence has implicated insulin, IGF-I and IGFBP-1 in colorectal carcinogenesis. [4] [5] [6] [7] Insulin has the potential to directly stimulate the growth of colonic epithelial and carcinoma cells in vitro, whereas its tumorigenic effects appear to operate mainly through the IGF axis via IGFBP-1 in vivo. [4] [5] [6] [7] Prolonged hyperinsulinemia decreases the production of IGFBP-1 from the liver and then increases free/bioavailable IGF-I, which has mitogenic and antiapoptotic properties. [4] [5] [6] [7] Of interest, IGFBP-1 has been reported to induce apoptosis in a human cancer cell line through IGFindependent mechanisms, 26 which may explain our observation that IGFBP-1 was more clearly associated with colorectal adenoma than IGF-I.
Our findings of a gender difference could be explained by unmeasured confounding factors particularly related to women, for example, administration of exogenous estrogens. Exogenous estrogens are hypothesized to exert a protective effect against colorectal neoplasia, 4 albeit this hypothesis is mainly based on investigations in postmenopausal women. 27, 28 In the present study, however, only onetenth of postmenopausal women were receiving hormone replacement therapy, and analysis that excluded them revealed a similar gender difference. Even if exogenous estrogens did exert a small confounding effect in this study, we would not rule out the presence of other unknown confounding factors, the influence of which is inevitable in observational studies. Apart from unknown confounding factors, we adjusted for several known risk factors of colorectal neoplasia, which likely made our results more valid. However, it is noteworthy that the accuracy and precision of measurement varied among risk factors and that adjustment for a risk factor with a substantial measurement error could not fully eliminate its confounding effect. Therefore, the present study could not completely avoid the influence of residual confounding stemming from measurement error.
Among the strengths of the present study, the provision of total colonoscopy to all study subjects likely decreased the possibility of misclassification between cases and controls.
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Conversely, a major limitation is its cross-sectional nature, and it is therefore difficult to make a definitive causal inference in our study setting. Moreover, the observed associations might be due to reverse causality. In contrast to colorectal cancer, however, it is unlikely that colorectal adenoma affects the amount of adipose tissue, a major determinant of insulin resistance and subsequent hyperinsulinemia, 8 because colorectal adenoma is an asymptomatic benign tumor. A second limitation is that we measured plasma levels, and not tissue levels, of biomarkers related to insulin and the IGF axis. Given that insulin and the IGF axis would directly affect the target cells to exert their tumorigenic effects, measurement of tissue levels might more precisely reflect the true exposure of target cells than that of plasma levels. Accordingly, the null findings in women do not exclude the possibility that insulin and the IGF axis are also associated with colorectal neoplasia in women, albeit the magnitude of such association appears weaker than that in men. Third, sample sizes for women were relatively small because of their lower prevalence of colorectal adenoma, and in some cases significant results could not be obtained because of limited statistical power. Finally, the present study was based not on incident but on prevalent cases, meaning that the ORs of colorectal adenoma presented in this study did not necessarily indicate the risk of 'developing' colorectal adenoma, but rather the risk of 'having' colorectal adenoma at a point in time, and should therefore be interpreted with caution. In summary, we observed a gender difference in the association of C-peptide, IGF-I and IGFBP-1 with colorectal adenoma. Our observations may add to evidence that insulin and the IGF axis act differently by gender in colorectal carcinogenesis, at least in its early stage. The findings of this study further our understanding of the complexities of the gender difference in the association between adiposity and colorectal neoplasia.
